Omontys Recall Issued by Manufacturer

October 11, 2013

Important Information

Attorneys working with ClassAction.org are no longer reviewing claims for this case. The information here is for reference only. A list of open investigations can be viewed here.

Comments |

At A Glance

This Alert Affects
Kidney dialysis patients who have been administered the drug Omontys.
Damages
Anaphylaxis, serious allergic reactions, death.
Company(ies)
Affymax Inc. and Takeda
Additional Details
Omontys treats anemia in kidney dialysis patients.
Date
On February 24, 2013, Takeda and Affymax announced a recall on all lots of Omontys.